GlassScriptPhysician profile
Adeeb Alshahrour
NPI 1225047921
$992.64
in general payments reported to CMS, 2019-2025
13 companies · $204 in 2025
The $204 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.75 · 2020: $53.63 · 2021: $60.79 · 2022: $365 · 2023: $179 · 2024: $105 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $487.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $363.57 | 2019-2023 | Lo Loestrin Fe, Liletta |
| Sumitomo Pharma America, INC. | $171.46 | 2023-2025 | Myfembree, Gemtesa |
| Hologic Sales and Service, LLC | $102.55 | 2020-2023 | Myosure Tissue Removal Device, Novasure, Coolseal Generator |
| Astellas Pharma US INC | $62.40 | 2024-2025 | Veozah |
| Medtronic, INC. | $60.58 | 2025 | Truclear |
| Gilead Sciences, INC. | $40.70 | 2025 | |
| Coopersurgical, INC. | $36.66 | 2022-2024 | Paragard T 380a |
| Mayne Pharma Commercial LLC | $35.83 | 2023-2024 | |
| Scynexis, INC. | $33.31 | 2022 | |
| Myovant Sciences INC. | $26.23 | 2022 | |
| Channel Medsystems, INC. | $23.60 | 2022 | |
| Coloplast Corp | $19.64 | 2025 | |
| Minerva Surgical, INC | $16.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adeeb Alshahrour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.